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Background: Previous studies reported that the incidence of intestinal spirochetosis was high in homosexual men,
especially those with Human Immunodeficiency Virus infection. The aim of the present study was to clarify the
clinicopathological features of intestinal spirochetosis in Japan with special reference to Human Immunodeficiency
Virus infection status and species types.
Methods: A pathology database search for intestinal spirochetosis was performed at Tokyo Metropolitan Cancer
and Infectious Disease Center Komagome Hospital between January 2008 and October 2011, and included 5265
consecutive colorectal biopsies from 4254 patients. After patient identification, a retrospective review of endoscopic
records and clinical information was performed. All pathology slides were reviewed by two pathologists. The length
of the spirochetes was measured using a digital microscope. Causative species were identified by polymerase chain
reaction.
Results: Intestinal spirochetosis was diagnosed in 3 out of 55 Human Immunodeficiency Virus-positive patients
(5.5%). The mean length of intestinal spirochetes was 8.5 μm (range 7–11). Brachyspira pilosicoli was detected by
polymerase chain reaction in all 3 patients. Intestinal spirochetosis was also diagnosed in 73 out of 4199 Human
Immunodeficiency Virus-negative patients (1.7%). The mean length of intestinal spirochetes was 3.5 μm (range 2–8).
The species of intestinal spirochetosis was identified by polymerase chain reaction in 31 Human Immunodeficiency
Virus-negative patients. Brachyspira aalborgi was detected in 24 cases (78%) and Brachyspira pilosicoli in 6 cases
(19%). Both Brachyspira aalborgi and Brachyspira pilosicoli were detected in only one Human Immunodeficiency
Virus-negative patient (3%). The mean length of Brachyspira aalborgi was 3.8 μm, while that of Brachyspira pilosicoli
was 5.5 μm. The length of Brachyspira pilosicoli was significantly longer than that of Brachyspira aalborgi (p < 0.01).
The lengths of intestinal spirochetes were significantly longer in Human Immunodeficiency Virus-positive patients
than in Human Immunodeficiency Virus-negative patients (p < 0.05).
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Conclusions: The incidence of intestinal spirochetosis was slightly higher in Human Immunodeficiency Virus-positive
patients than in Human Immunodeficiency Virus-negative patients. However, no relationship was found between
the Human Immunodeficiency Virus status and intestinal spirochetosis in Japan. Brachyspira pilosicoli infection may
be more common in Human Immunodeficiency Virus-positive patients with intestinal spirochetosis than in Human
Immunodeficiency Virus-negative patients with intestinal spirochetosis.
Keywords: Intestinal spirochetosis, Human Immunodeficiency Virus (HIV) infection, Colorectal biopsies, Brachispira
pilosicoli, Brachyspira aalborgiBackground
Intestinal spirochetosis (IS) is a condition in which colonic
and appendiceal epithelial cells are colonized by one of
two anaerobic spirochetes, either Brachyspira aalborgi,
measuring 2 to 6 μm in length, or Brachyspira pilosicoli,
measuring 4 to 20 μm in length (Figure 1) [1,2]. These
two species may be zoonotic because they have previously
been isolated from the feces of non-human primates and
other animals [3]. However, it has yet to be determined
whether IS is a pathogen or commensal inhabitant [4-6].
Previous studies reported that the incidence of IS was
high in homosexual men, especially those with Human
Immunodeficiency Virus (HIV) [7-10]. Although IS is
generally considered to be associated with immunocom-
promised states such as HIV infection, it has also been
detected in patients with a normal immune status
[5,11-13]. The incidence of IS in HIV-positive patients
has not yet been reported in Japan. Furthermore, the
prevalence of these species in HIV-positive patients
remains unclear [11,13-15]. Therefore, the aim of the
present study was to clarify the clinicopathological
features of IS in Japan with special reference to HIV
infection status and species types.Figure 1 Microscopic appearance of intestinal spirochetosis.
(H&E staining) A Brachyspira aalborgi. Basophilic fringes measuring 2
to 6 micrometers in length were observed on the surface epithelium.
B Brachyspira pilosicoli. Basophilic fringes measuring 4 to 20 micrometers
in length were observed on the surface epithelium.Methods
This study was approved by the Research Ethics
Committees at the Tokyo Metropolitan Cancer and
Infectious Disease Center Komagome Hospital, and
performed according to its guidance. Informed consent
was obtained from all participants. A pathology database
search for IS was performed at the Tokyo Metropolitan
Cancer and Infectious Disease Center Komagome
Hospital between January 2008 and October 2011,
and included 5265 consecutive colorectal biopsies
from 4254 patients. Patients consisted of 2558 men
and 1696 women, whose age ranged between 9 and
93 years with a mean age of 64 years. Fifty-five of these
patients were HIV-positive (1.3%) and 4199 were
HIV-negative (98.7%). After patient identification, a
retrospective review of endoscopic records and clinical
information was performed.
The database search identified 76 patients with IS. All
pathology slides were collected and reviewed by two
pathologists (YT and NF). All specimens were stained
with hematoxylin and eosin and examined under X
400 magnification. IS was identified by characteristic
basophilic fringes on the surface epithelium [13].
Immunostaining for spirochetosis was performed an
antibody against Treponema pallidum (polyclonal, dilution
1:300; Concord CA, Biocare Medical) where necessary
to confirm or refute the diagnosis. The lengths of
spirochetes were measured using a digital microscope
(Leica DMD 108).
Causative species were identified by PCR, which
amplified the species-specific portion of the 16S ribosomal
RNA gene. DNA from paraffin-embedded samples was
extracted using NucleoSpin Tissue (MACHEREY-NAGEL,
Duren, Germany). Pairs of primers were designed to detect
the genes for 16S ribosome RNA (16S rRNA) and NADH
oxidase (nox) in B. aalborgi and B. pilosicoli according to
the method described by Mikosza et al. [16]. The integrity
of paraffin-derived DNA was evaluated by PCR for
D8S348. The sequence of primers and size of products are
listed in Table 1.
All statistical analyses were performed using the JMP
statistics software package (SAS; version 9.0.2). The rela-
tionship between IS and clinicopathological characteristics
Table 1 Sequences of primers to detect the gene for 16S
rRNA, NADH oxydase (nox) of Brachyspira aalborgi and
Brachyspira pilosicoli












B. pilosicoli nox F: GTAACTCCTCCTATTGAG 465
R: GCACCATTAGGTAAAGTC
D8S348 F: ACCGACAGACTCTTGCCTCCAAA 408
R: TCACTCAGCTCCCATAACTTGGCAT
F, forward; R, reverse.
Table 2 Relationship between Clinicopathological
Findings and IS
IS positive IS negative
n = 76 n = 4178
Mean age, y (range) 59.3 (30–83) 64.1 (9–93) p < 0.01
Sex
Men (n = 2558) 58 (2.3%) 2500 (97.7%) p < 0.01
Women (n = 1696) 18 (1.1%) 1678 (98.9%)
HIV
Positive (n = 55) 3 (5.5%) 52 (94.5%) p = 0.09
Negative (n = 4199) 73 (1.7%) 4126 (98.3%)
Table 3 Relationship between size of IS and species
identified by PCR analysis




Case of both B. aalborgi and
B. pilosicoli
(μm) n = 25 n = 9 n = 1
0< 1 0 0
2< 11 0 1
3< 11 4 0
4< 2 2 0
6< 0 1 0
8< 0 2 0
p < 0.01.
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lyzed with the Chi-square test. Differences were considered
significant when the probability value was < 0.05.
Results
IS was detected in 76 out of 4254 patients (1.7%) by
hematoxylin and eosin staining. Immunostaining for
spirochetosis was performed to confirm this diagnosis in
8 cases. No cases were excluded by spirochetosis immu-
nostaining. Patients with IS consisted of 58 men and 18
women, whose age ranged from 30 to 83 years with a
mean age of 59.3 years. IS was diagnosed in 3 out of 55
HIV-positive patients (5.5%), and 73 out of 4199
HIV-negative patients (1.7%). A correlation was found
between IS and sex (p < 0.01) and age (p < 0.01) (Table 2).
No significant difference was found between the HIV
status and IS (p = 0.09).
IS was identified by characteristic 2–11 -μm-thick
basophilic fringes on the luminal surface of the epithe-
lium. The mean lengths of IS were 8.5 μm in HIV-positive
patients and 3.5 μm in HIV-negative patients. The length
of IS was significantly longer in HIV-positive patients than
in HIV-negative patients (p < 0.05).
The identification of species by PCR amplification was
assessed in 76 cases. Products of the gene for 16S rRNA
in B. aalborgi were detected in 24 cases. Products of the
gene for 16S rRNA in B. pilosicoli were detected in 9
cases. Both products of the genes for B. aalborgi and B.
pilosicoli were detected in 1 case. The integrity of
paraffin-derived DNA was evaluated by PCR for D8S348
in 42 cases which were negative for B. aalborgi and
B. pilosicoli. In 31 out of 42 cases, D8S348 was not
amplified suggesting the quality of DNA was insufficient.
In remaining 11 cases, DNA extracted from IS in infectedhuman tissue samples may be too small in relative amount
or too poor in quality. Another possibility is these cases
may have contained other species of spirochetes that have
yet to be characterized [17]. The length of IS was shown
in Table 3. The mean length of B. aalborgi was 3.8 μm
(range 2–4.5) and the mean length of B. pilosicoli was
5.5 μm (range 3.2-11). The length of IS was 2.5 μm
in patients with B. aalborgi and B. pilosicoli. The
length of B. pilosicoli was significantly longer than
that of B. aalborgi (p < 0.01).
B. pilosicoli was detected in all 3 IS cases with HIV
(100%). In HIV-negative patients, B. aalborgi was detected
in 24 cases (78%) and B. pilosicoli was detected in 6 cases
(19%). Both B. aalborgi and B. pilosicoli were detected in
only one HIV-negative patient (3%). All 3 HIV-positive IS
patients were male, not severely immunosuppressed
(CD4 lymphocyte cells; 668/μL, 798/μL and 317/μL),
had no other HIV-associated complications, showed
no histological abnormalities other than IS, and had
watery diarrhea. Most HIV-negative IS patients had
no clinical symptoms. Forty-seven patients underwent a
screening exam. Twelve patients underwent colonoscopy
as a hemoccult-positive rectal examination. Two patients
had hemorrhoids and one had ulcerative colitis. Eleven
HIV-negative IS patients had clinical symptoms (15%); 6
had abdominal pain, 4 had diarrhea or loose stools, and 1
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between the clinical symptoms and HIV status of IS
patients (p < 0.01). The characteristics of IS patients with
clinical symptoms were shown in Table 4. IS patients with
clinical symptoms consisted of 10 men and 4 women,
whose age ranged from 43 to 73 years with a mean age of
57.1 years. Endoscopically, tubular adenoma, or sessile
serrated adenoma or adenocarcinoma was detected in 10
out of 14 cases, whereas no specific endoscopic findings
were found in 4 out of 14 cases. The mean length of IS
was 4.5 μm (range 2.5-11). B. pilosicoli was detected in all
3 HIV-positive patients. Each species was successfully
identified in 6 out of 11 HIV-negative IS cases with clin-
ical symptoms. B. aalborgi was detected in 3 cases and B.
pilosicoli was detected in 2 cases. Both B. aalborgi and B.
pilosicoli were detected in 1 case.
Discussion
The prevalence of IS was previously reported to be
between 2 and 7% in Western countries and 11-34% in
less developed countries [18,19]. Our study revealed that
the incidence of IS in Japan was 1.7%, which was similar
to that in Western countries. The prevalence of IS was
previously reported to be approximately 54% in men
who have sex with men (MSM) and HIV-positive
patients [9,18,20]. On the other hand, Orenstein et al.
identified four patients with IS among 82 HIV-positive
patients [21]. Our study revealed that the incidence of IS
was slightly higher in HIV-positive patients than in
HIV-negative patients; however, no correlation was
found between the HIV status and IS in Japan. Fifty-five
HIV-positive and 4199 HIV-negative patients were evalu-
ated in our study, which was one of the largest reportedTable 4 Characteristics of IS patients with clinical symptoms
Case Ages as ranges Clinical Symptoms En
1 55-59 Abdominal pain, diarrhea TA
2 60-64 Abdominal pain TA
3 70-74 Abdominal pain TA
4 50-54 Abdominal pain TA
5 60-64 Abdominal pain A
6 45-49 Abdominal pain TA
7 55-59 Abdominal pain N
8 50-54 Diarrhea TA
9 60-64 Diarrhea TA
10 70-74 Loose stool SS
11 60-64 Loose stool H
12 45-49 HIV+, diarrhea N
13 40-44 HIV+, diarrhea N
14 45-49 HIV+, diarrhea N
F, female; M, male; TA, tubular adenoma; HP, hyperplastic polyp; SSAP, sessile serrat
ND, not detected.series of IS in HIV-positive and HIV-negative patients at a
single institution.
Previous studies showed that the length of B. aalborgi
was 2 to 6 μm and B. pilosicoli was 4 to 20 μm [1,2]. In
patients in which the species was identified by PCR
amplification, the length of B. aalborgi was 2 to 4.5 μm
and B. pilosicoli was 2.5 to 11 μm. The length of B.
pilosicoli was significantly longer than that of B. aalborgi
(p < 0.01), which was consistent with the findings of
previous studies. Furthermore, the length of IS in
HIV-positive patients was significantly longer than that of
IS in HIV-negative patients (p < 0.05).
B. aalborgi has been confirmed as the most prevalent
species in Western countries and Japan, while B. pilosicoli
is rare [6,13]. In the present study, B. pilosicoli was detected
in all 3 HIV-positive patients. The results of the present
study suggest that B. pilosicoli infections were more
common in HIV-positive patients with IS while B. aalborgii
infections may be more common in HIV-negative patients
with IS in Japan. The prevalence of these species in
HIV-positive patients has not yet been examined in
detail [11,13-15]. To the best of our knowledge, this
is the first study to show that B. pilosicoli infections
may be more common in HIV-positive patients with
IS based on one of the largest series composed of
HIV-positive and HIV-negative patients examined at a
single institution.
All 3 HIV-positive patients with IS in this study were
male, less severely immunosuppressed, and had watery
diarrhea. Anthony et al. reported that three HIV-positive
IS patients were symptomatic with diarrhea [22]. A
previous study demonstrated that IS caused chronic
diarrhea in HIV-positive men who have sex with men,doscopic findings Length of IS (μm) Results of PCR
3 A
4.2 P












ed adenoma/polyp; ADC, adenocarcinoma; A, B. aalborgi; P, B. pilosicoli;
Tateishi et al. BMC Infectious Diseases  (2015) 15:13 Page 5 of 5but were not severely immunosuppressed (CD4 lympho-
cyte cells >200/ μL) [20]. The clinicopathological findings
of IS cases in our study were similar to these findings.
B. aalborgi is generally considered to be a non-pathogenic
commensal, while B. pilosicoli is an opportunistic pathogen
[23]. All three HIV-positive patients with B. pilosicoli in our
study had watery diarrhea. In HIV-negative patients, B.
pilosicoli was more commonly detected in patients
with clinical symptoms (50%) than in patients without
clinical symptoms (16%). Furthermore, the prevalence
of B. pilosicoli was markedly higher in patients with
clinical symptoms than in patients without clinical
symptoms (p = 0.02). This result supports the pathogenic
potential of B. pilosicoli. Since the number of patients was
too small to clarify the clinical significance of B. pilosicoli
infection, further investigations are required.
Conclusion
In this study, we revealed the clinicopathological features
of IS in Japan. The incidence of IS was slightly higher in
HIV-positive patients than in HIV-negative patients.
However, no relationship was found between the HIV
status and IS. Brachyspira pilosicoli infection may be
more common in HIV-positive patients with IS than in
HIV-negative patients with IS.
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